Gowling WLG (Canada) LLP
With over 700 lawyers, patent and trademark agents in offices across Canada, Gowling WLG LLP is one of Canada’s largest national full-service law firms. As a recognized leader in Intellectual Property and strategic business solutions that encompass everything from startup financing to IPOs, Gowling WLG is at the forefront of emerging fields, including biotechnology. Gowling WLG’s Life Sciences Industry Group draws on the expertise of over 120 legal and technical professionals who understand the unique needs of Canada’s dynamic biotechnology sector. This multidisciplinary approach provides an expansive vision and broad skill set – and solutions that are uniquely tailored to the industry. Professionals in Gowling WLG’s Life Sciences Industry Group are ranked as Canadian and world leaders in their respective specialties. With decades of experience advising in the industry, along with our national and bilingual presence, Gowling WLG is well-placed to serve the needs of Canada’s Life Sciences Industry.
The Life Sciences Industry Group advises clients on a broad range of issues, including: Intellectual Property: providing advice on all aspects of patent prosecution; advocacy, including patent litigation under the Patented Medicines (Notice of Compliance) Regulations; all aspects of patent and trade mark protection and infringement litigation, including filing applications, dispute resolution and domain name issues; life cycle management; conducting IP audits, due diligence and developing portfolio strategies; Food and Drugs Act: providing advice on various regulatory and compliance issues including obtaining marketing approval, packaging, labeling and advertising; providing advice and advocacy on product recalls including product liability advice; Corporate: providing advice on mergers and acquisitions; corporate, income and commodity tax; corporate finance; venture capital financing; commercial leasing; licensing, distribution agreements and strategic alliances; Internet Pharmacy: advising on issues of concern relating to Internet pharmacies, including representation in key provincial markets; Price Controls: advising on pricing issues and provincial formulary listing; representation before the Patented Medicine Prices Review Board and the Federal Court; Competition Law and International Trade: providing advice and representation relating to NAFTA, the WTO TRIPs Agreement, the Canadian International Trade Tribunal and the Canadian Competition Bureau; Public Policy: providing advice on government relations, regulatory affairs and strategic communications; providing strategic policy advice; Privacy: ensuring compliance with privacy legislation, conducting privacy audits and assessments, and representation on privacy issues before the Privacy Commissioner. Gowling WLG’s Life Sciences Industry Group has in-depth experience in areas that are critical to the success of biotech companies, including: agriculture, biochemistry, bioinformatics, biologicals, biomedical devices, chemistry, combinatorial chemistry, functional genomics, high throughput procedures, immunology, metabolomics, molecular biology, molecular farming, nanotechnology, pharmaceuticals and proteomics.
April 21, 2022
Intellectual Property Made Easy: Goxl Offers Growing Businesses an Online Entry Point into the Universe of IP Protection
April 8, 2022
Managing Intellectual Property Names Gowling WLG The Canadian “Patent Contentious Firm of the Year”
March 25, 2022
IP Transactions in Life Sciences: Data Transfer, Sharing and Exclusivity in China and Canada
January 31, 2022
Dan Misutka Joins Gowling WLG’S Administrative Law Group
No current content.